About
Novocure Ltd (NASDAQ:NVCR) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 1 2026
Novocure to Report First Quarter 2026 Financial Results
Mar 26 2026
Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer
Mar 2 2026
Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer
Feb 27 2026
Novocure to Participate in 2026 Leerink Global Healthcare Conference
Feb 26 2026
Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update
Financials
Revenue
$655.35 M
Market Cap
$1.25 B
EPS
-1.22
Google Übersetzer